- GPC Biotech nets €78.6mm in combined offering
- Altana's Byk Gulden and Genome Pharmaceuticals sign deal
- GPC AG to buy Mitotix in all-stock deal
- GPC Biotech licenses bryostatin-1 from Arizona State
- GPC licenses NeoTherapeutics' satraplatin
- Altana, GPC enter drug discovery agreement
- Byk Gulden in functional genomics deal with GPC Biotech
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. email@example.com.
All fields are required.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.